|
Neoplasm Metastasis
|
|
0.030 |
GeneticVariation
|
BEFREE |
The allele del of rs145204276 is associated with a remarkably lower incidence of cancer progression and metastasis.
|
29557411 |
2018 |
|
Neoplasm Metastasis
|
|
0.030 |
GeneticVariation
|
BEFREE |
We confirmed that rs145204276 of GAS5 is a functional variant associated with the susceptibility and metastasis of GC.
|
29602737 |
2018 |
|
Colorectal Carcinoma
|
|
0.030 |
GeneticVariation
|
BEFREE |
Previous studies showed that genetic variant rs145204276 in the promoter region of GAS5 was associated with the development of human cancer including colorectal cancer and hepatocellular cancer.
|
30013899 |
2018 |
|
Colorectal Carcinoma
|
|
0.030 |
GeneticVariation
|
BEFREE |
In current study, we investigated the possible association between susceptibility of lung cancer and GAS5 rs145204276, which showed contradictory roles in carcinogenesis of colorectal cancer and hepatocellular carcinoma.
|
29207621 |
2017 |
|
Colorectal Carcinoma
|
|
0.030 |
GeneticVariation
|
BEFREE |
Taken together, our findings provided strong evidence for the hypothesis that GAS5 rs145204276 were significantly associated with the susceptibility and progression of CRC.
|
27863421 |
2016 |
|
Neoplasm Metastasis
|
|
0.030 |
GeneticVariation
|
BEFREE |
In current two-stage, case-control study, we systematically evaluated the potential role of lncRNA GAS5 and its genetic variation rs145204276 in the development and metastasis process of CRC in a Chinese population.
|
27863421 |
2016 |
|
Malignant neoplasm of prostate
|
|
0.020 |
GeneticVariation
|
BEFREE |
Patients with PC were recruited and grouped according to their specific genotypes of rs55829688 and rs145204276.
|
30317620 |
2019 |
|
Prostate carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
We aimed to investigate the effect of variant rs145204276 of GAS5 on the prostate cancer susceptibility and clinicopathologic characteristics.
|
31673232 |
2019 |
|
Prostate carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
Patients with PC were recruited and grouped according to their specific genotypes of rs55829688 and rs145204276.
|
30317620 |
2019 |
|
Malignant neoplasm of prostate
|
|
0.020 |
GeneticVariation
|
BEFREE |
We aimed to investigate the effect of variant rs145204276 of GAS5 on the prostate cancer susceptibility and clinicopathologic characteristics.
|
31673232 |
2019 |
|
Neoplasms
|
|
0.020 |
GeneticVariation
|
BEFREE |
The frequency of the allele del of rs145204276 were compared between the patients and the controls to evaluate the impact of tumor susceptibility and the correlation of clinicopathological variables.
|
31673232 |
2019 |
|
Stomach Carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
The variant rs145204276 of GAS5 is associated with the development and prognosis of GC.
|
29557411 |
2018 |
|
Malignant neoplasm of stomach
|
|
0.020 |
GeneticVariation
|
BEFREE |
The variant rs145204276 of GAS5 is associated with the development and prognosis of GC.
|
29557411 |
2018 |
|
Stomach Carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
We confirmed that rs145204276 of GAS5 is a functional variant associated with the susceptibility and metastasis of GC.
|
29602737 |
2018 |
|
Malignant neoplasm of stomach
|
|
0.020 |
GeneticVariation
|
BEFREE |
We confirmed that rs145204276 of GAS5 is a functional variant associated with the susceptibility and metastasis of GC.
|
29602737 |
2018 |
|
Liver carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
Previous studies showed that genetic variant rs145204276 in the promoter region of GAS5 was associated with the development of human cancer including colorectal cancer and hepatocellular cancer.
|
30013899 |
2018 |
|
Malignant neoplasm of colon and/or rectum
|
|
0.020 |
GeneticVariation
|
BEFREE |
Previous studies showed that genetic variant rs145204276 in the promoter region of GAS5 was associated with the development of human cancer including colorectal cancer and hepatocellular cancer.
|
30013899 |
2018 |
|
Malignant neoplasm of colon and/or rectum
|
|
0.020 |
GeneticVariation
|
BEFREE |
In current study, we investigated the possible association between susceptibility of lung cancer and GAS5 rs145204276, which showed contradictory roles in carcinogenesis of colorectal cancer and hepatocellular carcinoma.
|
29207621 |
2017 |
|
Neoplasms
|
|
0.020 |
GeneticVariation
|
BEFREE |
Taken together, our findings provided strong evidence for the hypothesis that GAS5 rs145204276 were significantly associated with the susceptibility of lung cancer, and GAS5 functions as a tumor suppressor in carcinogenesis of lung cancer.
|
29207621 |
2017 |
|
Liver carcinoma
|
|
0.020 |
GeneticVariation
|
BEFREE |
In current study, we investigated the possible association between susceptibility of lung cancer and GAS5 rs145204276, which showed contradictory roles in carcinogenesis of colorectal cancer and hepatocellular carcinoma.
|
29207621 |
2017 |
|
Secondary malignant neoplasm of lymph node
|
|
0.010 |
GeneticVariation
|
BEFREE |
In conclusion, the rs145204276 polymorphic genotype of GAS5 can predict the risk of lymph </span>node metastasis.
|
31673232 |
2019 |
|
Tumor Cell Invasion
|
|
0.010 |
GeneticVariation
|
BEFREE |
The results shown that patients who carries genotype ins/del or del/del at SNP rs145204276 showed decreased risk of pathological lymph node metastasis disease (OR=0.545, p=0.043) and risk of seminal vesicle invasion (OR=0.632, p=0.022) comparing to with genotype ins/ins.
|
31673232 |
2019 |
|
Breast Carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
The rs145204276 del allele might protect against the development of BC via inducing the promoter activity by binding to transcriptional factor specificity protein 1, and finally resulting in higher levels of GAS5.
|
30846409 |
2019 |
|
Febrile Convulsions
|
|
0.010 |
GeneticVariation
|
BEFREE |
Association between indel polymorphism (rs145204276) in the promoter region of lncRNA GAS5 and the risk of febrile convulsion.
|
30656683 |
2019 |
|
Malignant neoplasm of breast
|
|
0.010 |
GeneticVariation
|
BEFREE |
The rs145204276 del allele might protect against the development of BC via inducing the promoter activity by binding to transcriptional factor specificity protein 1, and finally resulting in higher levels of GAS5.
|
30846409 |
2019 |